Brigatinib is an oral medication recommended by Oncologists in the treatment of NSCLC. Its approval as an orphan drug has expanded therapeutic possibilities in lung cancer management. Brigatinib is considered as a drug of choice for those patients resistant to Osimertinib. Brigatinib price in India is a trend to understand its relevance. It is available in tablet form with three strengths including 30mg, 90mg and 180mg. Just like any other latest treatment option for cancer, the expectations are high for this drug. Patients must consult a clinical expert for prescription. Data recommendations can only be interpreted by treating physicians for their relevance.
Brigatinib – Update on FDA and EMA approvals
Brigatinib got its initial FDA approval in 2016. This was granted based on the orphan drug status. In 2017, it was given the approval in the second line settings for metastatic NSCLC. This is specific to ALK-Positive cases. It was subsequently granted its EMA approval in 2018. That way it is a relatively new drug from the Asian perspective. Alunbrig was the innovation of Ariad Pharmaceuticals, a reputed research oriented company. Now Takeda owns Ariad and therefore the sourcing and Alunbrig cost would be determined by the new entity. Research products often generate enthusiasm and it is only natural for this drug to have expanded the scope of treatment in many parts of the world.
- Medical Oncologists who also specialize in treating lung cancer patients often recommend advanced medications like Alunbrig in India. Ariad Pharmaceuticals is credited for developing therapeutic options for several rare disease conditions. They now have an expanded focus with new market expansions.
- NSCLC is a very common type of cancer classified under lung cancers. Targeted therapies are possible with the evaluation of specific markers and expressions like ALK and EGFR. With more research outcomes expected in the future, the scope for using Alunbrig can certainly expand. Experts are keenly following the outcomes and subsequent possibilities.
Brigatinib in India – What is the procurement procedure?
It’s not an option to buy Alunbrig in India at a regular pharmacy outlet or at a distributor’s place. Brigatinib price in India is not fixed with MRP price cap. This is attributed to registration related technicalities and logistical constraints. But, there is no restriction for the Oncologists to prescribe Brigatinib in India. Patients can be given the choice to procure and get treated with latest medical options. Import option facilitated by reputed companies is ideal in such cases.
At this point in time, Alunbrig is sourced from Europe, Germany to be specific. This is more applicable for Indian patients. Patients would save a lot of time and hassle if they go by their treating physician’s advice. Suppliers recommended by the medical experts based on their past experience are usually reliable.
Professionally managed procurement for Brigatinib in India
At this point in time, Alunbrig is sourced from Europe, Germany to be specific. This is more applicable for Indian patients. Patients would save a lot of time and hassle if they go by their treating physician’s advice. Suppliers recommended by the medical experts based on their past experience are usually reliable.
Contact Noel Biotech – +91 9677010046 / +91 992977766; nhs@noelbiotech.com